162 related articles for article (PubMed ID: 19057948)
1. CXCR2 and RET single nucleotide polymorphisms in pancreatic cancer.
Donahue TR; Hines OJ
World J Surg; 2009 Apr; 33(4):710-5. PubMed ID: 19057948
[TBL] [Abstract][Full Text] [Related]
2. The G691S RET polymorphism increases glial cell line-derived neurotrophic factor-induced pancreatic cancer cell invasion by amplifying mitogen-activated protein kinase signaling.
Sawai H; Okada Y; Kazanjian K; Kim J; Hasan S; Hines OJ; Reber HA; Hoon DS; Eibl G
Cancer Res; 2005 Dec; 65(24):11536-44. PubMed ID: 16357163
[TBL] [Abstract][Full Text] [Related]
3. Experimental implication of celiac ganglionotropic invasion of pancreatic-cancer cells bearing c-ret proto-oncogene with reference to glial-cell-line-derived neurotrophic factor (GDNF).
Okada Y; Takeyama H; Sato M; Morikawa M; Sobue K; Asai K; Tada T; Kato T; Manabe T
Int J Cancer; 1999 Mar; 81(1):67-73. PubMed ID: 10077155
[TBL] [Abstract][Full Text] [Related]
4. The relationship between overexpression of glial cell-derived neurotrophic factor and its RET receptor with progression and prognosis of human pancreatic cancer.
Zeng Q; Cheng Y; Zhu Q; Yu Z; Wu X; Huang K; Zhou M; Han S; Zhang Q
J Int Med Res; 2008; 36(4):656-64. PubMed ID: 18652760
[TBL] [Abstract][Full Text] [Related]
5. CXC-chemokine/CXCR2 biological axis promotes angiogenesis in vitro and in vivo in pancreatic cancer.
Matsuo Y; Raimondo M; Woodward TA; Wallace MB; Gill KR; Tong Z; Burdick MD; Yang Z; Strieter RM; Hoffman RM; Guha S
Int J Cancer; 2009 Sep; 125(5):1027-37. PubMed ID: 19431209
[TBL] [Abstract][Full Text] [Related]
6. Expression of glial cell line-derived neurotrophic factor correlates with perineural invasion of bile duct carcinoma.
Iwahashi N; Nagasaka T; Tezel G; Iwashita T; Asai N; Murakumo Y; Kiuchi K; Sakata K; Nimura Y; Takahashi M
Cancer; 2002 Jan; 94(1):167-74. PubMed ID: 11815973
[TBL] [Abstract][Full Text] [Related]
7. High glucose promotes cell proliferation and enhances GDNF and RET expression in pancreatic cancer cells.
Liu H; Ma Q; Li J
Mol Cell Biochem; 2011 Jan; 347(1-2):95-101. PubMed ID: 20960036
[TBL] [Abstract][Full Text] [Related]
8. The role of glial cell line-derived neurotrophic factor (GDNF) and integrins for invasion and metastasis in human pancreatic cancer cells.
Funahashi H; Okada Y; Sawai H; Takahashi H; Matsuo Y; Takeyama H; Manabe T
J Surg Oncol; 2005 Jul; 91(1):77-83. PubMed ID: 15999351
[TBL] [Abstract][Full Text] [Related]
9. Blockade of the chemokine receptor CXCR2 inhibits pancreatic cancer cell-induced angiogenesis.
Wente MN; Keane MP; Burdick MD; Friess H; Büchler MW; Ceyhan GO; Reber HA; Strieter RM; Hines OJ
Cancer Lett; 2006 Sep; 241(2):221-7. PubMed ID: 16458421
[TBL] [Abstract][Full Text] [Related]
10. Duffy antigen receptor for chemokines (DARC) expressing in cancer cells inhibits tumor progression by suppressing CXCR2 signaling in human pancreatic ductal adenocarcinoma.
Maeda S; Kuboki S; Nojima H; Shimizu H; Yoshitomi H; Furukawa K; Miyazaki M; Ohtsuka M
Cytokine; 2017 Jul; 95():12-21. PubMed ID: 28214673
[TBL] [Abstract][Full Text] [Related]
11. Alteration of integrin expression by glial cell line-derived neurotrophic factor (GDNF) in human pancreatic cancer cells.
Funahashi H; Takeyama H; Sawai H; Furuta A; Sato M; Okada Y; Hayakawa T; Tanaka M; Manabe T
Pancreas; 2003 Aug; 27(2):190-6. PubMed ID: 12883269
[TBL] [Abstract][Full Text] [Related]
12. Endoneurial macrophages induce perineural invasion of pancreatic cancer cells by secretion of GDNF and activation of RET tyrosine kinase receptor.
Cavel O; Shomron O; Shabtay A; Vital J; Trejo-Leider L; Weizman N; Krelin Y; Fong Y; Wong RJ; Amit M; Gil Z
Cancer Res; 2012 Nov; 72(22):5733-43. PubMed ID: 22971345
[TBL] [Abstract][Full Text] [Related]
13. The CXC chemokine receptor 2, CXCR2, is the putative receptor for ELR+ CXC chemokine-induced angiogenic activity.
Addison CL; Daniel TO; Burdick MD; Liu H; Ehlert JE; Xue YY; Buechi L; Walz A; Richmond A; Strieter RM
J Immunol; 2000 Nov; 165(9):5269-77. PubMed ID: 11046061
[TBL] [Abstract][Full Text] [Related]
14. Infrequent detectable somatic mutations of the RET and glial cell line-derived neurotrophic factor (GDNF) genes in human pituitary adenomas.
Yoshimoto K; Tanaka C; Moritani M; Shimizu E; Yamaoka T; Yamada S; Sano T; Itakura M
Endocr J; 1999 Feb; 46(1):199-207. PubMed ID: 10426588
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of microRNA-216a confers protection against yttrium aluminium garnet laser-induced retinal injury
Hu XB; Fu SH; Luo QI; He JZ; Qiu YF; Lai W; Zhong M
J Biosci; 2018 Dec; 43(5):985-1000. PubMed ID: 30541958
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of RET induces perineurial invasion of pancreatic adenocarcinoma.
Amit M; Na'ara S; Leider-Trejo L; Binenbaum Y; Kulish N; Fridman E; Shabtai-Orbach A; Wong RJ; Gil Z
Oncogene; 2017 Jun; 36(23):3232-3239. PubMed ID: 28092668
[TBL] [Abstract][Full Text] [Related]
17. Activation of phosphatidylinositol 3-kinase and extracellular signal-regulated kinase is required for glial cell line-derived neurotrophic factor-induced migration and invasion of pancreatic carcinoma cells.
Veit C; Genze F; Menke A; Hoeffert S; Gress TM; Gierschik P; Giehl K
Cancer Res; 2004 Aug; 64(15):5291-300. PubMed ID: 15289335
[TBL] [Abstract][Full Text] [Related]
18. Expression of glial cell line-derived neurotrophic factor family members and their receptors in pancreatic cancers.
Ito Y; Okada Y; Sato M; Sawai H; Funahashi H; Murase T; Hayakawa T; Manabe T
Surgery; 2005 Oct; 138(4):788-94. PubMed ID: 16269310
[TBL] [Abstract][Full Text] [Related]
19. Prokineticin-1 (Prok-1) works coordinately with glial cell line-derived neurotrophic factor (GDNF) to mediate proliferation and differentiation of enteric neural crest cells.
Ngan ES; Shum CK; Poon HC; Sham MH; Garcia-Barcelo MM; Lui VC; Tam PK
Biochim Biophys Acta; 2008 Mar; 1783(3):467-78. PubMed ID: 18006159
[TBL] [Abstract][Full Text] [Related]
20. RET isoforms contribute differentially to invasive processes in pancreatic ductal adenocarcinoma.
Lian EY; Hyndman BD; Moodley S; Maritan SM; Mulligan LM
Oncogene; 2020 Oct; 39(41):6493-6510. PubMed ID: 32884116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
